Malmis, Lorenza M.

HRN: 13-56-41  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/18/2025
CEFTRIAXONE 1G (VIAL)
07/18/2025
07/24/2025
IV
2g
OD
Typhoid Fever
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: